{{Rsnum
|rsid=355689
|Gene=CXCL13
|Chromosome=4
|position=77586643
|Orientation=plus
|GMAF=0.2599
|Gene_s=CXCL13
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 42.5 | 48.7
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.9 | 99.1
| YRI | 20.4 | 49.0 | 30.6
| ASW | 31.6 | 47.4 | 21.1
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 2.0 | 22.8 | 75.2
| LWK | 39.1 | 50.0 | 10.9
| MEX | 1.7 | 34.5 | 63.8
| MKK | 31.4 | 51.9 | 16.7
| TSI | 8.8 | 35.3 | 55.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23250934
|Title=Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk
|OA=1
}}

{{PMID Auto
|PMID=17903292
|Title=A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}